ChoA Pharmaceutical Co., Ltd. announced that it has received KRW 12 billion in funding from Moorim Capital Co., Ltd., Dongbu Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm
October 23, 2017
Share
On October 24, 2017, ChoA Pharmaceutical Co., Ltd. (KOSDAQ:A034940) closed the transaction.
CHOA PHARMACEUTICAL CO,.LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. It also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.
ChoA Pharmaceutical Co., Ltd. announced that it has received KRW 12 billion in funding from Moorim Capital Co., Ltd., Dongbu Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm
CHOA PHARMACEUTICAL CO., LTD. 
